Eili T. Kase
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Correction: Development of three-dimensional primary human myospheres as culture model of skeletal muscle cells for metabolic studies.
Journal: Frontiers in bioengineering and biotechnology
Published: August 18, 2025
The SGLT2 inhibitor empagliflozin promotes increased fatty acid oxidation in skeletal muscle cells.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 20, 2025
Reduced lipid and glucose oxidation and reduced lipid synthesis in AMPKα2-/- myotubes.
Journal: Archives of physiology and biochemistry
Published: January 09, 2025
The use of three-dimensional primary human myospheres to explore skeletal muscle effects of in vivo krill oil supplementation.
Journal: In vitro models
Published: October 31, 2024
Krill oil supplementation in vivo promotes increased fuel metabolism and protein synthesis in cultured human skeletal muscle cells.
Journal: Frontiers in nutrition
Published: June 21, 2024
Time-dependent reduction in oxidative capacity among cultured myotubes from spinal cord injured individuals.
Journal: Acta physiologica (Oxford, England)
Published: September 09, 2023
Development of three-dimensional primary human myospheres as culture model of skeletal muscle cells for metabolic studies.
Journal: Frontiers in bioengineering and biotechnology
Published: December 23, 2022
Pancreatic Cancer Cell-Conditioned, Human-Derived Primary Myotubes Display Increased Leucine Turnover, Increased Lipid Accumulation, and Reduced Glucose Uptake.
Journal: Metabolites
Published: October 12, 2022
Energy metabolism in skeletal muscle cells from donors with different body mass index.
Journal: Frontiers in physiology
Published: July 01, 2022
Insight Into the Metabolic Adaptations of Electrically Pulse-Stimulated Human Myotubes Using Global Analysis of the Transcriptome and Proteome.
Journal: Frontiers in physiology
Published: April 25, 2022
Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells.
Journal: Molecular biology reports
Published: November 18, 2021
Last Updated: 09/26/2026